Turner D. Wibbelsman
- Ophthalmology top 2%
- Retinal Diseases and Treatments 20
- Glaucoma and retinal disorders 11
- Retinal and Optic Conditions 9
- Ocular Infections and Treatments 7
- Intraocular Surgery and Lenses 5
- Ocular Diseases and Behçet’s Syndrome 3
-
- Retinal Imaging and Analysis 13
- Retinal and Macular Surgery 6
- Co-authors
- Anthony ObeidSamir PatelAngell ShiJason HsuAllen C. HoDurga S. BorkarPhilip StoreySunir J. Garg
- Journals
- SHILAP Revista de lepidopterología (1 paper)Ophthalmology (4 papers)European Urology (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Turner D. Wibbelsman
28 papers receiving 350 citations
Peers
Comparison fields: 5 of 49
- Ophthalmology 319
- Radiology, Nuclear Medicine and Imaging 234
- Clinical Biochemistry 8
- Pharmaceutical Science 6
- Neurology 12
Countries citing papers authored by Turner D. Wibbelsman
This map shows the geographic impact of Turner D. Wibbelsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Turner D. Wibbelsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Turner D. Wibbelsman more than expected).
Fields of papers citing papers by Turner D. Wibbelsman
This network shows the impact of papers produced by Turner D. Wibbelsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Turner D. Wibbelsman. The network helps show where Turner D. Wibbelsman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Turner D. Wibbelsman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 13 | |
| 3 | Visual outcomes in Eyes Lost to Follow Up with Diabetic Macular Edema treated with Anti-Vascular Endothelial Growth Factor | 2020 | 2 |
| 4 | 2020 | 5 | |
| 5 | 2020 | 4 | |
| 6 | 2020 | 4 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 16 | |
| 9 | 2020 | 5 | |
| 10 | 2020 | 1 | |
| 11 | Factors predicting distribution and practice patterns of retina providers across the United States (US) | 2019 | 2 |
| 12 | 2019 | 12 | |
| 13 | 2019 | 3 | |
| 14 | 2019 | 17 | |
| 15 | Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab | 2019 | 2 |
| 16 | 2019 | 38 | |
| 17 | 2019 | 52 | |
| 18 | 2019 | 23 | |
| 19 | 2019 | 13 | |
| 20 | 2019 | 8 |
About Turner D. Wibbelsman
Turner D. Wibbelsman is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Clinical Biochemistry, having authored 31 papers that have together received 362 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (20 papers), Retinal Imaging and Analysis (13 papers), Glaucoma and retinal disorders (11 papers), Retinal and Optic Conditions (9 papers), Ocular Infections and Treatments (7 papers), Retinal and Macular Surgery (6 papers), Intraocular Surgery and Lenses (5 papers) and Ocular Diseases and Behçet’s Syndrome (3 papers). The work is most often cited by research in Ophthalmology (319 citations), Radiology, Nuclear Medicine and Imaging (234 citations) and Clinical Biochemistry (8 citations). Turner D. Wibbelsman has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Anthony Obeid, Samir Patel, Angell Shi, Jason Hsu, Allen C. Ho, Durga S. Borkar, Philip Storey, Sunir J. Garg, Daniel Su and Omesh P. Gupta. Their work appears in journals such as SHILAP Revista de lepidopterología, Ophthalmology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.